4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-23-100077
Options or other derivatives
- Chief Financial Officer acquired 253,123 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
O'Loughlin Steve · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-28 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +253,123 | 253,123 | D |
Loading xslF345X05/ownership.xml…